{
    "2014-08-30": [
        "Strong trial results for Novartis' chronic heart failure drug LCZ696. 20% c/v mortality relative risk reduction.",
        "Nice 3-minute video from NEJM summarizes LCZ696 PARADIGM-HF findings. #ESCCongress",
        "Strong trial results for Novartis' chronic heart failure drug LCZ696. 20% c/v mortality relative risk reduction."
    ]
}